Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2003
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027151A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003WO2003027113A1 1,6-naphthyridine derivatives as antidiabetics
04/03/2003WO2003027112A1 1, 8-naphthyridine derivatives as antidiabetics
04/03/2003WO2003027111A1 Chemical compounds
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027090A2 Bicyclic heterocycles as rxr ligands
04/03/2003WO2003027077A1 Water-soluble phenylpyridazine derivatives and drugs containing the same
04/03/2003WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
04/03/2003WO2003026693A2 Inhibitors of costimulation by 0x40 and their use against infectious diseases
04/03/2003WO2003026692A2 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex
04/03/2003WO2003026691A2 Use of hmgb1 for the activation of dendritic cells
04/03/2003WO2003026690A1 Incapacitated whole-cell immunogenic bacterial compositions
04/03/2003WO2003026687A1 Delivery system for biological component
04/03/2003WO2003026663A1 Process for making substituted pyrazoles
04/03/2003WO2003026660A1 An enantiomerically pure diarylmethylpiperazine and methods of using same
04/03/2003WO2003026640A1 Treating food allergies and/or food intolerances
04/03/2003WO2003026579A2 Combination therapies for immune mediated diseases
04/03/2003WO2003026568A2 Androstanes as androgen receptor modulators
04/03/2003WO2003026561A2 Flavonoids for treatment of diabetes
04/03/2003WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
04/03/2003WO2003026430A1 Treatment of allergic rhinitis
04/03/2003WO2003011295B1 Fexofenadine polymorph
04/03/2003WO2003002722A3 T cell regulatory genes and methods of use thereof
04/03/2003WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7
04/03/2003WO2002100332A3 Isoxazoline compounds having mif antagonist activity
04/03/2003WO2002094270A3 Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases
04/03/2003WO2002088336A3 Genetically modified yt cell line and use thereof
04/03/2003WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES
04/03/2003WO2002062330A3 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
04/03/2003WO2002044419A3 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
04/03/2003WO2002042444A8 Fungal gene cluster associated with pathogenesis
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003WO2002009748A9 Innate immune system-directed vaccines
04/03/2003WO2002000860A3 Novel proteases
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003US20030065362 Method for genetic immunization
04/03/2003US20030065186 Antihistamines, antiallergens, bronchodilator
04/03/2003US20030065174 Antiinflammatory agents; analgesics
04/03/2003US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/03/2003US20030065007 Analgesics; psychological disorders; antidepressants
04/03/2003US20030065006 Viricides; anticancer agents
04/03/2003US20030065005 Heterocyclic ether substituted imidazoquinolines
04/03/2003US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents
04/03/2003US20030064993 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
04/03/2003US20030064987 Immunology moderators; interleukin antagonist; anticancer agents
04/03/2003US20030064983 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders
04/03/2003US20030064968 Viricides, anticarcinogneic agents
04/03/2003US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
04/03/2003US20030064944 Controlling cell differentiation, cell proliferation
04/03/2003US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064914 Copolymer-1 improvements in compositions of copolymers
04/03/2003US20030064503 Device
04/03/2003US20030064412 123 human secreted proteins
04/03/2003US20030064374 Detecting neuronal stress in humans; obtain sample, measure phosphodiesterase concentration, evaluate for neuronal stress
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064114 For vasodilatation and inhibition of transplant rejection
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents
04/03/2003US20030064069 Specific binding members for TGFbeta1
04/03/2003US20030064067 Inducing differentiation and/or promoting proliferation of regulatory T cells, comprising allowing a CD3 agonist and a 4C8 antigen agonist to act on an immunocyte expressing CD3 and 4C8 antigens
04/03/2003US20030064065 35 kappaD tumor associated protein antigen: uses and methods detection
04/03/2003US20030064064 Administering formulation that inhibits activity of IgE(immunoglobulin E) sufficient to decrease the activity of IgE and administering to the subject second formulation amount of the antigen sufficient to modulate the immune response
04/03/2003US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy
04/03/2003CA2778208A1 Delivery system for biological component
04/03/2003CA2463039A1 1,6-naphthyridine derivatives as antidiabetics
04/03/2003CA2461806A1 Water-soluble phenylpyridazine derivatives and medicines containing the same
04/03/2003CA2461714A1 Treatment of chronic joint inflammation
04/03/2003CA2461710A1 Incapacitated whole-cell immunogenic bacterial compositions
04/03/2003CA2461666A1 Combination therapies for immune mediated diseases
04/03/2003CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
04/03/2003CA2461563A1 Flavonoids for treatment of diabetes
04/03/2003CA2461529A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003CA2461132A1 1, 8-naphthyridine derivatives as antidiabetics
04/03/2003CA2461095A1 Process for making substituted pyrazoles
04/03/2003CA2461091A1 Use of hmgb1 for the activation of dendritic cells
04/03/2003CA2460953A1 Proteins associated with cell growth, differentiation, and death
04/03/2003CA2459943A1 Androstanes as androgen receptor modulators
04/03/2003CA2453985A1 Receptors and membrane-associated proteins
04/03/2003CA2446904A1 Delivery of drug esters through an inhalation route
04/02/2003EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes
04/02/2003EP1298208A2 Ribozymes targeting a hiv tat sequence
04/02/2003EP1298203A2 Diagnosis and treatment of autoimmune diseases
04/02/2003EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1
04/02/2003EP1298137A1 Novel substance having physiological activity, process for producing the same, and use
04/02/2003EP1297846A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
04/02/2003EP1297837A1 Remedies for allergic diseases and process for producing the same
04/02/2003EP1297172A2 Methods for producing modified glycoproteins
04/02/2003EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
04/02/2003EP1297142A2 Dual specificity antibodies and methods of making and using
04/02/2003EP1297137A2 Gp286 nucleic acids and polypeptides
04/02/2003EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor
04/02/2003EP1297130A2 G-protein coupled receptors
04/02/2003EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
04/02/2003EP1297121A2 Purging of cells using viruses
1 ... 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 ... 1172